Evaluation of molecular strategies to develop a live dengue vaccine
- 1 July 1998
- journal article
- Published by Elsevier in Clinical and Diagnostic Virology
- Vol. 10 (2-3) , 173-179
- https://doi.org/10.1016/s0928-0197(98)00035-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Growth-Restricted Dengue Virus Mutants Containing Deletions in the 5′ Noncoding Region of the RNA GenomeVirology, 1995
- A Live Attenuated Dengue-L Vaccine Candidate (45AZ5) Passaged In Primary Dog Kidney Cell Culture Is Attenuated And Immunogenic For HumansThe Journal of Infectious Diseases, 1994
- FLAVIVIRUS GENOME ORGANIZATION, EXPRESSION, AND REPLICATIONAnnual Review of Microbiology, 1990
- Sequence and secondary structure analysis of the 5′-terminal region of flavivirus genome RNAVirology, 1988
- Conserved elements in the 3′ untranslated region of flavivirus RNAs and potential cyclization sequencesJournal of Molecular Biology, 1987
- The nucleotide sequence of dengue type 4 virus: Analysis of genes coding for nonstructural proteinsVirology, 1987
- Cloning full-length dengue type 4 viral DNA sequences: Analysis of genes coding for structural proteinsVirology, 1986
- The 3′-nucleotides of flavivirus genomic RNA form a conserved secondary structureVirology, 1986
- Nucleotide Sequence of Yellow Fever Virus: Implications for Flavivirus Gene Expression and EvolutionScience, 1985
- Experimental Studies on Dengue: I. Isolation, Identification and Modification of the VirusThe Journal of Infectious Diseases, 1952